MedMen
$1.65Bpaper valuation
// OVERVIEW
MedMen was worth $1.65 billion in 2019 when it called itself the Apple Store of weed and operated 33 dispensaries across California, Nevada, and Arizona. In 2023, it filed for bankruptcy with $411 million in debt and liquidated every store. Today it is a case study in what happens when a company mistakes interior design for a durable competitive advantage in a commodity market.
// HQ
Los Angeles, United States
// STATUS
PRIVATE
// FOUNDED
2010
// TIER
The Unicorn Herd · $1B – $9.9B
// PRIMARY SECTOR
cannabis
// FOUNDERS
// FUNDING ROUNDS
// SECTORS SERVED
// TECHNOLOGY
MedMen built retail environments with iPad-equipped budtenders, minimalist shelving, and architectural lighting that convinced venture capitalists that cannabis dispensaries could command premium multiples. The technology was a point-of-sale system and an aesthetic. The competitive moat was nonexistent.
// WOWLS ASSESSMENT
MedMen raised $1 billion burning through $50 million per quarter on Manhattan billboards, Super Bowl ads, and executive compensation packages that paid co-founder Adam Bierman $1.5 million in 2019 while the company lost $274 million. The operating model required sustained capital infusion to cover retail leases and inventory costs in a market where regulatory complexity made profitability structurally difficult and competitors could replicate the store experience for one-tenth the overhead. When cannabis hype peaked in 2019 and capital markets closed, MedMen had 33 stores, no path to profitability, and debt covenants it could not meet. By 2022, the stores were closing one by one. By 2023, the company was bankrupt.
// WHY WOWLS HUNTS THIS
The carcass demonstrates that brand premium in commodity markets requires either cost advantage or supply constraint — MedMen had neither and burned a billion dollars discovering it. WOWLS archives this as a reference specimen for pattern recognition in future cannabis pitches.
// VALUATION NOTE
Peak valuation of $1.65B in 2019 based on Canadian Securities Exchange listing (CSE: MMEN). Company filed Chapter 11 bankruptcy in June 2023 and liquidated all assets.
VERDICT: ZOMBIECORN — MEDMEN SPENT $1 BILLION PROVING THAT APPLE STORE AESTHETICS DO NOT MAKE WEED RETAIL A VENTURE-SCALE BUSINESS
// PACK DEBATE
// PACK DEBATE — be the first to weigh in
Google account required — no spam, no nonsense
// LOADING INTEL…
// BROADCAST INTEL
// SIMILAR TARGETS
// INTEL UPDATED: MAY 2026
// INTELLIGENCE DISCLAIMER: Assessments represent editorial opinion based on publicly available data including filings, press reports, and market data as of the date shown. Valuations are approximate. Not financial or investment advice.
// FULL NETWORK ACCESS
🚀 Founder Briefing: Instantly sort investors by Sector, Stage, & Round — direct links to websites for all 1,030 unicorns & backing VCs included.
Don't just track MedMen.
Master the entire 1,030 unicorn company intelligence network.
Stop analyzing tech monopolies one page at a time. Instantly filter, sort, and isolate the exact venture capital firms, angel investors, and corporate funds backing your specific market vertical. Find investors that fit your sector and deploy your pitch with direct outbound links to every target asset in the database — 1,030 targets total.
Acquire Intel →// 5 TIERS · PAYPAL SECURED
// ENGAGE THE FULL ARSENAL
Done reading on MedMen?
Unlock the entire 1,030-company hitlist and 1,030 investor contacts.
Full structural breakdowns. Founder dossiers. VC outreach data. Threat-level intel updated continuously.
→ Deploy 5-Tier Order Form// ARBAN · ZUUN · MINGHAN · TUMEN · KHAN